UBS Group’s Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 PCPC.WS Stock Holding History

UBS Group's PCPC.WS Position: Q4 2022 in Review

UBS Group sold out of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) in Q4 2022, closing a stake of 5,306 shares — an estimated $1K sold.

UBS Group first reported a position in PCPC.WS in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold PCPC.WS as of Q4 2022.

• UBS Group reported no remaining Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position as of Q4 2022 after selling out during the quarter.
• UBS Group sold 5,306 Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 shares in Q4 2022, an estimated $1K.
• UBS Group first reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in Q1 2021 and held it in 3 quarters.
• UBS Group's Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position peaked at $2K in Q2 2022.
• 0 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.